Select Page

We speak science. It’s in our DNA.

With our biomedical research backgrounds and biotech communications experience, we translate the science and technology into the value story that matters for your stakeholders and business goals.

Jessica Yingling, Ph.D.

President and Founder

Jessica founded Little Dog Communications Inc. to work with companies and organizations that, through research, innovation and new technologies are helping develop tomorrow’s medicines and re-imagining the future of healthcare.

The DNA of communications is both science and art.
“It’s more than a website, a PowerPoint or a press release, it’s your story.  It needs to inspire others, so together you can achieve something important.”

– Jessica Yingling, Ph.D., President of Little Dog Communications

Biotech and healthcare communications have an added layer of complexity due to the science. Jessica merges a biomedical research background with communications EQ to find the best way to convey new science and technologies to motivate audiences and stakeholders.

Before founding Little Dog Communications in 2011, Jessica was director of corporate communications at Fate Therapeutics, where she built and successfully executed a complete corporate communications program that established Fate as a pioneering company in stem cell medicines. This program led to numerous company awards and recognitions, including being named one of the most innovative biotechs by Fast Company.

Previous to Fate, Jessica was at Porter Novelli Life Sciences, where she gained experience working with a wide range of accounts from start-up biotechs translating early stage technology to public life sciences companies with marketed products.

Jessica achieved her Ph.D. in biomedical sciences from University of California, San Diego, where she was awarded a National Science Foundation pre-doctoral fellowship. She is author in multiple top-tier review articles and research papers, including Cell. She earned a B.S. with honors in biochemistry and art history from the University of Arizona, where she received a number of academic and research scholarships and awards.


What started from the joy of placing a client in the Associated Press over 13 years ago, has transformed into a career of storytelling for high profile brands and local companies alike.  Kelly Kass is a passionate and trusted public relations expert who takes a strategic approach in counseling clients on all facets of media relations including media training, story mining, pitch strategy, and media communication. Previously, as vice president at Weber Shandwick where she spent a decade of her career, Kelly was called on throughout the company as the media specialist who could always navigate the complex media landscape, often because of her exceptional media relationships at top tier media outlets. For Little Dog Communications, Kelly led the media strategy on the FDA approval of the first blood test to aid in the evaluation of traumatic brain injury developed by Banyan Biomarkers and secured coverage in the ABC News, Associated Press, CNBC, and CNN. Kelly consistently secures national placements for clients including: ABC World News, The Today Show, Nightline, CNN, CNN Money, Forbes and The New York Times. Past and current clients include: Sutter Health, Mount Auburn Hospital, Nike, Burt's Bees, Ocean Spray, Del Monte, General Motors, and Verizon. Kelly has also been published as the author of “Securing Coverage Takes Smart Storytelling and Careful Follow up,” in the PR News Media Relations Guide Book. Kelly holds a Bachelor of Arts in public relations and a minor in fine arts from Quinnipiac University.  After many cold Boston winters, Kelly now enjoys living in San Diego.
Charya is a former chemist turned science communicator. She currently supports clients of Little Dog Communications in multiple public relations projects. She also freelances as a science writer. Prior to joining Little Dog's team of consultants, Charya was a part of CG Life's public relations department, where she gained experience in science communications and marketing. During her time there, she created impactful, effective content pieces, and secured and coordinated potent media opportunities for many clients in the biotech, medtech, and pharma industries. Charya completed her Ph.D. and M.A. in chemistry at Rice University, Houston, where she was awarded a pre-doctoral fellowship. At Rice, her research into biomaterials and work with startup company NangioTx helped her develop insight into commercializing scientific technologies born in the lab. Additionally, by serving as a volunteer patient advocate at the MD Anderson Cancer Center, Charya was able to familiarize herself with the rapid developments in the field of oncology. Charya obtained her B.S in chemistry and biochemistry from the University of Colombo, located in her home country, Sri Lanka. She also served as an assistant lecturer there, before moving to the United States for her doctorate.
Madeline Wukusick is the creative director and founder of Communiqué Creative. She received her degree in Visual Communications from Indiana University and cut her (design) teeth working in advertising in New York City on campaigns for companies such as Saks Fifth Avenue, Tiffany, and Campbell's. Years later when she landed on the West Coast, she was impressed by the hub of science and innovation in San Diego and founded Communiqué to fill a need for smart design in research and biotech. Madeline draws on her experience in advertising and expertise in visual communications to transform complex, nuanced ideas into succinct, engaging visuals. She works with clients spanning the fields of life sciences, medicine, biotech, sustainability, and conservation.

Pin It on Pinterest